Company: CDT
Filing Date: 2025-04-16
Form Type: 8-K
Source: 0001641172-25-005036
Chunk: 4

Company: CDT Equity Inc.
Filing Date: 2025-04-16
Form: 8-K
Item: Item 9.01
Chunk 4
---
Item
9.01 Financial Statements and Exhibits.

(d)
Exhibits.

  Exhibit      Description                                                                                
      No.                                                                                                 
     10.1      Additional                                                                                 
               Agreement, dated March 31, 2025, between Sarborg Limited and Conduit Pharmaceuticals Inc.  
     99.1      Press                                                                                      
               Release, dated April 16, 2025                                                              
 ──────────────────────────────────────────────────────────────────────────────────────────────────────────
      104      Cover Page Interactive                                                                     

SIGNATURES

Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.

                      CONDUIT PHARMACEUTICALS INC.                               
  April 16, 2025      By:                               /s/ Andrew               
                      Name:                             Andrew Regan             
                      Title:                            Chief Executive Officer